In an older adult without dementia who has a history of panic attacks, anxiety, and depression, what is the recommended first‑line treatment and when is aripiprazole appropriate as augmentation?

First-Line Treatment for Anxiety and Depression in Older Adults Without Dementia

For an older adult without dementia presenting with panic attacks, anxiety, and depression, the first-line treatment is an SSRI or SNRI antidepressant, with cognitive behavioral therapy (CBT) as an equally effective alternative or adjunct. 1, 2, 3

Initial Treatment Approach

Pharmacotherapy

Start with an SSRI or SNRI at approximately 50% of the standard adult starting dose due to increased risk of adverse effects in older adults 2. Preferred agents include:

• Escitalopram 5-10 mg daily (increase to 10-20 mg)
• Sertraline 25-50 mg daily (increase to 50-200 mg)
• Citalopram 10-20 mg daily (maximum 20-40 mg)

Avoid paroxetine and fluoxetine in older adults due to greater anticholinergic effects and risk of agitation, respectively 2.

Psychotherapy

Cognitive behavioral therapy is equally effective as antidepressants and should be offered as first-line treatment, either alone or combined with medication 3. CBT addresses both depression and anxiety symptoms simultaneously and avoids medication-related risks in older adults.

Combined Treatment

The combination of antidepressant plus CBT may provide superior outcomes compared to either alone, particularly for patients with both panic attacks and depression 3.

When to Consider Aripiprazole Augmentation

Aripiprazole augmentation is appropriate only after failure of at least one adequate antidepressant trial (adequate dose for 6-8 weeks minimum) 1, 4, 3.

Specific Criteria for Augmentation:

• Patient has not achieved remission after 6-8 weeks of therapeutic-dose SSRI/SNRI 1, 4
• Depression severity remains moderate to severe (not responding to first-line treatment)
• This is specifically for treatment-resistant depression, NOT for primary anxiety or panic disorder 5, 6

Aripiprazole Dosing in Older Adults:

When augmentation is indicated, start aripiprazole at 2-5 mg daily (significantly lower than standard adult dosing) 6, 7. The evidence suggests:

• Optimal efficacy occurs at 2-5 mg daily in older adults 6, 7
• Maximum dose should not exceed 10-15 mg daily 6, 8
• Higher doses (above 5 mg) do not provide additional benefit but increase side effects 7

Evidence for Aripiprazole in Older Adults:

A high-quality randomized trial demonstrated that aripiprazole augmentation achieved 44% remission versus 29% with placebo in adults ≥60 years with treatment-resistant depression (NNT = 6.6) 6. A more recent pragmatic trial (OPTIMUM) confirmed aripiprazole augmentation improved well-being significantly more than switching antidepressants 5.

Critical Safety Considerations

Monitoring Requirements:

• Assess for akathisia (restlessness) and Parkinsonism at each visit—these occurred in 26% and 17% of older adults respectively 6
• Monitor for falls risk, particularly when combining with benzodiazepines
• Evaluate suicidal ideation closely during first 8 weeks of any antidepressant treatment 1, 9

What NOT to Use:

• Do NOT use aripiprazole as first-line treatment for anxiety or panic disorder 10
• Avoid benzodiazepines for long-term anxiety management in older adults due to fall risk, cognitive impairment, and dependence 11
• Do NOT use antipsychotics (including aripiprazole) for non-psychotic anxiety alone 12, 10

Treatment Timeline

Reassess response at 6 weeks after initiating or adjusting treatment 4. If inadequate response:

1. Optimize antidepressant dose first
2. Consider switching to different SSRI/SNRI or adding CBT
3. Only after failure of above, consider aripiprazole augmentation 3, 5

Continue successful antidepressant treatment for 4-12 months minimum after first episode; indefinitely for recurrent depression 2.

Common Pitfalls to Avoid

• Do not jump to augmentation without adequate first-line trial (6-8 weeks at therapeutic dose)
• Do not use standard adult doses of aripiprazole—older adults require 50-75% dose reduction
• Do not prescribe aripiprazole for anxiety symptoms alone—it is only indicated for treatment-resistant depression augmentation 9, 10
• Do not overlook akathisia—this distressing side effect may worsen anxiety symptoms and is often mistaken for worsening psychiatric illness